A new Harvard Chan School study shows that using a GLP-1 receptor agonist and maintaining a healthy lifestyle are complementary strategies, rather than substitutes, in improving cardiovascular outcomes among patients with diabetes.Read More
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients | Harvard T.H. Chan School of Public Health
